These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 8327729
1. Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Laing RW, Warrington AP, Graham J, Britton J, Hines F, Brada M. Radiother Oncol; 1993 Apr; 27(1):22-9. PubMed ID: 8327729 [Abstract] [Full Text] [Related]
2. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Hudes RS, Corn BW, Werner-Wasik M, Andrews D, Rosenstock J, Thoron L, Downes B, Curran WJ. Int J Radiat Oncol Biol Phys; 1999 Jan 15; 43(2):293-8. PubMed ID: 10030252 [Abstract] [Full Text] [Related]
3. Preliminary report of a phase I study of combined fractionated stereotactic radiosurgery and conventional external beam radiation therapy for unfavorable gliomas. Regine WF, Patchell RA, Strottmann JM, Meigooni A, Sanders M, Young AB. Int J Radiat Oncol Biol Phys; 2000 Sep 01; 48(2):421-6. PubMed ID: 10974456 [Abstract] [Full Text] [Related]
4. Phase I dose escalation trial of vandetanib with fractionated radiosurgery in patients with recurrent malignant gliomas. Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C. Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):51-7. PubMed ID: 21035955 [Abstract] [Full Text] [Related]
5. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, Evans JJ, Hyslop T, Pequignot E, Downes B, Comber E, Maltenfort M, Dicker AP, Werner-Wasik M. J Clin Oncol; 2010 Jun 20; 28(18):3048-53. PubMed ID: 20479391 [Abstract] [Full Text] [Related]
6. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Shepherd SF, Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE, Brada M. Int J Radiat Oncol Biol Phys; 1997 Jan 15; 37(2):393-8. PubMed ID: 9069312 [Abstract] [Full Text] [Related]
7. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas. Schwer AL, Damek DM, Kavanagh BD, Gaspar LE, Lillehei K, Stuhr K, Chen C. Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):993-1001. PubMed ID: 17967517 [Abstract] [Full Text] [Related]
8. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas. Gannett D, Stea B, Lulu B, Adair T, Verdi C, Hamilton A. Int J Radiat Oncol Biol Phys; 1995 Sep 30; 33(2):461-8. PubMed ID: 7673034 [Abstract] [Full Text] [Related]
9. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma. VanderSpek L, Fisher B, Bauman G, Macdonald D. Can J Neurol Sci; 2008 Mar 30; 35(1):57-64. PubMed ID: 18380278 [Abstract] [Full Text] [Related]
10. Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas. McKenzie JT, Guarnaschelli JN, Vagal AS, Warnick RE, Breneman JC. J Neurooncol; 2013 Jul 30; 113(3):403-9. PubMed ID: 23589034 [Abstract] [Full Text] [Related]
11. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB. Int J Radiat Oncol Biol Phys; 1999 Dec 01; 45(5):1133-41. PubMed ID: 10613305 [Abstract] [Full Text] [Related]
12. Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control. Ogura K, Mizowaki T, Arakawa Y, Sakanaka K, Miyamoto S, Hiraoka M. Cancer Med; 2013 Dec 01; 2(6):942-9. PubMed ID: 24403268 [Abstract] [Full Text] [Related]
14. Combined stereotactic split-course fractionated gamma knife radiosurgery and conventional radiation therapy for unfavorable gliomas: a phase I study. Regine WF, Patchell RA, Strottmann JM, Meigooni A, Sanders M, Young B. J Neurosurg; 2000 Dec 15; 93 Suppl 3():37-41. PubMed ID: 11143260 [Abstract] [Full Text] [Related]
15. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Tsao MN, Mehta MP, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, Mills M, Rogers CL, Souhami L. Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):47-55. PubMed ID: 16111571 [Abstract] [Full Text] [Related]
16. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma. Clarke J, Neil E, Terziev R, Gutin P, Barani I, Kaley T, Lassman AB, Chan TA, Yamada J, DeAngelis L, Ballangrud A, Young R, Panageas KS, Beal K, Omuro A. Int J Radiat Oncol Biol Phys; 2017 Nov 15; 99(4):797-804. PubMed ID: 28870792 [Abstract] [Full Text] [Related]
17. Fractionated stereotactic radiosurgery with volumetric modulated arc therapy (Rapid Arc) for reradiation in recurrent high grade gliomas. Anand AK, Kumar P, Patir R, Vaishya S, Bansal AK, Chaudhoory AR, Punnakal AU, Malhotra H, Munjal RK. J Cancer Res Ther; 2014 Nov 15; 10(1):97-102. PubMed ID: 24762494 [Abstract] [Full Text] [Related]
18. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ. Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):374-9. PubMed ID: 15667955 [Abstract] [Full Text] [Related]
19. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D. J Clin Oncol; 2005 Dec 01; 23(34):8863-9. PubMed ID: 16314646 [Abstract] [Full Text] [Related]
20. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):511-9. PubMed ID: 16168843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]